Clinical Research

First US patient enrolled in device study to reduce coronary microvascular dysfunction
The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
Advances in leadless conduction and Bachmann’s bundle pacing next frontier in physiologic pacing
Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.
Vibrations used to extract EP leads in first-in-human study
A novel vibration-based extraction technique appears to offer safety, efficiency and a simple, rapid, alternative to conventional lead removal.
AFib patients with gout face greater stroke risk—but therapy can help
Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.
Boston researchers land $9M grant to advance molecular neuroimaging
Researchers in Boston are set to co-lead a long-term study on the aging brain and factors that make individuals more vulnerable to neural injury and cognitive decline.

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs.

cardiologist doctor physician patient black diverse hypertension

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours.

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

Colchicine before PCI: New research tracks the long-term impact on heart health

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

New research on AI-based CCTA assessments wins Best Abstract at SCCT 2023

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up.

Clinical Research

First US patient enrolled in device study to reduce coronary microvascular dysfunction

Advances in leadless conduction and Bachmann’s bundle pacing next frontier in physiologic pacing

Vibrations used to extract EP leads in first-in-human study

AFib patients with gout face greater stroke risk—but therapy can help

Boston researchers land $9M grant to advance molecular neuroimaging